Masafumi Iijima

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

Takeshi Ozeki, Taisei Mushiroda, Amara Yowang et al. · Human Molecular Genetics · 2010 · 510 citations · Full text

Life Sciences, Genetics, Pharmacology +13

Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome

Mikiko Tohyama, Koji Hashimoto, Masaki Yasukawa et al. · British Journal of Dermatology · 2007 · 339 citations

Medicine, Internal Medicine, Pharmacology +13

Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Chie Sotozono, Mayumi Ueta, Eiji Nakatani et al. · American Journal of Ophthalmology · 2015 · 136 citations

Medicine, Dermatology, Ophthalmology +9

Sequelae in 145 patients with drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: Survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions ( <scp>ASCAR</scp> )

Yoko Kano, Mikiko Tohyama, Michiko Aihara et al. · The Journal of Dermatology · 2015 · 119 citations

Life Sciences, Dermatology, Internal Medicine +15

Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS)

Kohei Ogawa, Hironori Morito, Ayako Hasegawa et al. · Journal of Dermatological Science · 2012 · 89 citations · Full text

Life Sciences, Immunology, Pharmacology +17